Literature DB >> 18064412

Pharmacology of neurotransmitter transport into secretory vesicles.

Farrukh A Chaudhry1, Jean-Luc Boulland, Monica Jenstad, May K L Bredahl, Robert H Edwards.   

Abstract

Many neuropsychiatric disorders appear to involve a disturbance of chemical neurotransmission, and the mechanism of available therapeutic agents supports this impression. Postsynaptic receptors have received considerable attention as drug targets, but some of the most successful agents influence presynaptic processes, in particular neurotransmitter reuptake. The pharmacological potential of many other presynaptic elements, and in particular the machinery responsible for loading transmitter into vesicles, has received only limited attention. The similarity of vesicular transporters to bacterial drug resistance proteins and the increasing evidence for regulation of vesicle filling and recycling suggest that the pharmacological potential of vesicular transporters has been underestimated. In this review, we discuss the pharmacological effects of psychostimulants and therapeutic agents on transmitter release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064412     DOI: 10.1007/978-3-540-74805-2_4

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  27 in total

1.  The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.

Authors:  Hakeem O Lawal; Hui-Yun Chang; Ashley N Terrell; Elizabeth S Brooks; Dianne Pulido; Anne F Simon; David E Krantz
Journal:  Neurobiol Dis       Date:  2010-05-26       Impact factor: 5.996

Review 2.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.

Authors:  Alexei Verkhratsky; Michela Matteoli; Vladimir Parpura; Jean-Pierre Mothet; Robert Zorec
Journal:  EMBO J       Date:  2016-01-12       Impact factor: 11.598

3.  Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice - effects of peripheral axotomy or hindpaw inflammation.

Authors:  M Malet; C A Vieytes; K H Lundgren; R P Seal; E Tomasella; K B Seroogy; T Hökfelt; G F Gebhart; P R Brumovsky
Journal:  Neuroscience       Date:  2013-05-31       Impact factor: 3.590

Review 4.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  Cholinergic neurons in the mouse rostral ventrolateral medulla target sensory afferent areas.

Authors:  Ruth L Stornetta; Conrad J Macon; Thanh M Nguyen; Melissa B Coates; Patrice G Guyenet
Journal:  Brain Struct Funct       Date:  2012-03-30       Impact factor: 3.270

Review 6.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

Review 7.  The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

Authors:  Harald H Sitte; Michael Freissmuth
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

Review 8.  Trafficking of vesicular neurotransmitter transporters.

Authors:  Hao Fei; Anna Grygoruk; Elizabeth S Brooks; Audrey Chen; David E Krantz
Journal:  Traffic       Date:  2008-05-26       Impact factor: 6.215

9.  Vesicular glutamate and GABA transporters sort to distinct sets of vesicles in a population of presynaptic terminals.

Authors:  Jean-Luc Boulland; Monica Jenstad; Amber J Boekel; Floris G Wouterlood; Robert H Edwards; Jon Storm-Mathisen; Farrukh A Chaudhry
Journal:  Cereb Cortex       Date:  2008-05-22       Impact factor: 5.357

Review 10.  SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.

Authors:  Hakeem O Lawal; David E Krantz
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.